The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 91.40
Bid: 91.30
Ask: 92.00
Change: 0.00 (0.00%)
Spread: 0.70 (0.767%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 91.40
CLI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition

8 Jan 2020 07:00

RNS Number : 0598Z
CLS Holdings PLC
08 January 2020
 

 

Release date: 8 January 2020

Embargoed until: 07:00 am

 

 

CLS Holdings plc ("CLS")

announces the acquisition of 'TWENTY' Kingston Road, Staines-upon-Thames

and the completion of the sale of Quayside Lodge in Fulham, London

 

CLS announces that it has unconditionally exchanged contracts to acquire 'TWENTY' Kingston Road in Staines for £19.0 million excluding costs. Completion is planned for 3 February 2020.

 

TWENTY comprises 44,230 sq. ft (4,109 sqm) of grade A, multi-let office space in Staines. The building has excellent transport links and is a short walk away from Staines train station which has quick connections to London and Reading. Heathrow Airport is a short drive away.

 

The asset is currently let to four tenants with a WAULT of 5.4 years to breaks and has a vacancy of 23%. It has an attractive net initial yield of 5.3%, increasing to 7.0% once fully let. TWENTY underwent an extensive refurbishment in 2014 and achieved a BREEAM Excellent accreditation and EPC 'B' rating.

 

CLS also announces that it has completed the sale of Quayside Lodge in Fulham, London for £19.0 million to a private developer. As previously announced, CLS achieved planning permission in 2018 for a new 10-storey residential development.

 

Fredrik Widlund, Chief Executive Officer of CLS, commented:

"We continue to see a range of acquisition opportunities in the UK that are highly suited to our portfolio. TWENTY Kingston Road offers strong reversionary potential with a yield of 7% once fully let and the acquisition is in line with our opportunistic approach. We will also continue to recycle capital, when opportunities like Quayside arise, into new investments in the UK, Germany and France."

 

-ends-

 

For further information, please contact:

 

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

Fredrik Widlund, Chief Executive Officer

Andrew Kirkman, Chief Financial Officer

+44 (0)20 7582 7766

 

Liberum Capital Limited

Richard Crawley

Jamie Richards

+44 (0)20 3100 2222

 

Whitman Howard

Hugh Rich

+44 (0)20 7659 1261

 

Elm Square Advisers Limited

Jonathan Gray

+44 (0)20 7823 3695

 

Smithfield Consultants (Financial PR)Alex Simmons

Rob Yates

+44 (0)20 3047 2546

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQKZGGMNNGGGZM
Date   Source Headline
4th May 201711:21 amRNSCompletion of Sale of Vauxhall Square
28th Apr 20172:52 pmRNSDirector/PDMR Shareholding
26th Apr 20174:02 pmRNSShare Subdivision Timetable
26th Apr 20173:26 pmRNSDirector/PDMR Shareholding
26th Apr 20173:21 pmRNSResult of AGM
5th Apr 201712:14 pmRNSSale of Vauxhall Square
24th Mar 20174:39 pmRNSPublication of Annual Report and Notice of AGM
23rd Mar 20177:00 amRNSDisposal
21st Mar 20177:00 amRNSAcquisition
15th Mar 20174:07 pmRNSDividend Timetable
8th Mar 20177:00 amRNSFinal Results
7th Mar 20173:57 pmRNSDirectorate Changes
8th Feb 20177:00 amRNSIntroduction of Dividend
18th Jan 20174:22 pmRNSTrading Statement
11th Jan 20177:00 amRNSAcquisitions
16th Dec 20164:40 pmRNSSecond Price Monitoring Extn
16th Dec 20164:35 pmRNSPrice Monitoring Extension
12th Dec 201610:57 amRNSDirector/PDMR Shareholding
30th Nov 201610:24 amRNSDirector/PDMR Shareholding
23rd Nov 20167:00 amRNSTrading Statement
3rd Nov 201611:46 amRNSDirector/PDMR Shareholding
24th Oct 20164:21 pmRNSDirector/PDMR Shareholding
24th Oct 20167:00 amRNSDisposals
11th Oct 201610:26 amRNSDirector/PDMR Shareholding
28th Sep 20169:29 amRNSDirector/PDMR Shareholding
27th Sep 20165:16 pmRNSDirector/PDMR Shareholding
22nd Sep 20164:30 pmRNSCompletion of Tender Offer and Total Voting Rights
13th Sep 20163:31 pmRNSResult of Tender Offer
7th Sep 20167:00 amRNSCompletion of Düsseldorf acquisition
26th Aug 20164:48 pmRNSTender Offer
17th Aug 20167:00 amRNSHalf-year Report
11th Jul 20167:00 amRNSAcquisitions
4th Jul 20164:57 pmRNSTR-1: Notification of Major Interest in Shares
28th Jun 20165:07 pmRNSDirector/PDMR Shareholding
27th Jun 20165:27 pmRNSDirector/PDMR Shareholding
16th Jun 20164:40 pmRNSSecond Price Monitoring Extn
16th Jun 20164:35 pmRNSSecond Price Monitoring Extn
16th Jun 201612:02 pmRNSPrice Monitoring Extension
8th Jun 20165:48 pmRNSCorrection - Transaction in Own Shares & TVR
1st Jun 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
31st May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
27th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
26th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
25th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
24th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
23rd May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
20th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
18th May 20163:26 pmRNSDirectors' Details
18th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights
17th May 20167:00 amRNSTransaction in Own Shares & Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.